The agency also said that Medicare beneficiaries will for the first time be able to choose prescription drug plans that include broad sets of insulin priced at no more than $35 per month, per prescription.
Earlier this year, CMS launched its Part D senior savings model, which caps monthly insulin copays at $35. The agency predicts the program will save beneficiaries an average of $446 per year.
CMS said that Part D premiums have decreased by 12 percent since 2017, and enrollment has increased by 16.7 percent during the same time period.
Read CMS’ full news release here.
More articles on pharmacy:
Moderna’s coronavirus vaccine research alleged target of Chinese hackers
Operation Warp Speed: a timeline so far
25% of diabetes patients rationing treatments amid pandemic, survey finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
